Skip to main content
See every side of every news story
Published • loading... • Updated

U.S. approval of cheap, generic HIV prevention shot may boost global rollout

Summary by Medical Brief
The US Food & Drug Administration has approved a generic version of lenacapavir (Yeztugo), the world’s only twice-a-year shot to prevent HIV – a big step toward making the drug available inexpensively and more quickly in 120 low- and middle-income countries, reports MedPage Today. The drug is expected to cost $40 a year per person in the […]

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Science broke the news in Washington, United States on Wednesday, November 11, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal